Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vomiting
Clinical narrative: Mild malaise/ feeling sick and no interference with activity; Mild injection site pain and no interference with activity; Mild injection site redness; Mild fever (100.4 to 101.2 °F); Joint pain and no interference with activity; Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting; Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Mild malaise/ feeling sick and no interference with activity), VACCINATION SITE PAIN (Mild injection site pain and no interference with activity), VACCINATION SITE ERYTHEMA (Mild injection site redness), PYREXIA (Mild fever (100.4 to 101.2 °F)) and ARTHRALGIA (Joint pain and no interference with activity) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In December 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In December 2023, the patient experienced MALAISE (Mild malaise/ feeling sick and no interference with activity), VACCINATION SITE PAIN (Mild injection site pain and no interference with activity), VACCINATION SITE ERYTHEMA (Mild injection site redness), PYREXIA (Mild fever (100.4 to 101.2 °F)), ARTHRALGIA (Joint pain and no interference with activity), VOMITING (Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting) and NAUSEA (Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting). At the time of the report, MALAISE (Mild malaise/ feeling sick and no interference with activity), VACCINATION SITE PAIN (Mild injection site pain and no interference with activity), VACCINATION SITE ERYTHEMA (Mild injection site redness), PYREXIA (Mild fever (100.4 to 101.2 °F)), ARTHRALGIA (Joint pain and no interference with activity), VOMITING (Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting) and NAUSEA (Mild nausea/ vomiting and no interference with activity or 1-2 episodes of nausea/ vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2023, Body temperature: Mild fever (100.4 to 101.2 degree F).     The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       The Subject ID was reported.   The Subject ID was reported.  No concomitant medication was reported.   Patient had experienced malaise, vaccination site pain, vaccination site erythema, pyrexia, arthralgia, vomiting and nausea anytime during the 2 days after COVID-19 vaccination, which occurred on Sunday, 17-Dec-2023 and Monday, 18-Dec-2023.   No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2024-756177 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-756177:Pateint 45 out of 49